
|Videos|January 10, 2023
Developing an active surveillance protocol for patients receiving a diagnosis of prostate cancer after HoLEP
Author(s)Urology Times staff
Ashley E. Ross, MD, PhD, provides an overview of his institution’s new protocol for this subset of patients.
Advertisement
In this video, Ashley E. Ross, MD, PhD, discusses an active surveillance protocol for patients undergoing holmium laser enucleation of the prostate for benign prostatic hyperplasia who subsequently receive a diagnosis of prostate cancer. Ross is an associate professor of urology at Northwestern University Feinberg School of Medicine in Chicago, Illinois.
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA grants clearance to Hugo robotic-assisted surgery system for urologic procedures
2
Apalutamide is linked to fewer CNS-related conditions in patients with nmCRPC
3
Prostate MRI is linked with higher sensitivity, NPV vs micro-ultrasound in pilot study
4
BOND-003: Cretostimogene yields durable 24-month responses in high-grade NMIBC
5


















